Rita R Alloway

13PUBLICATIONS
47CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 24, 2025
Belatacept Pharmacokinetic Analysis of Belatacept Early Steroid Withdrawal Trial (BEST) to Clinical Outcomes and Compared With Reported BENEFIT and BENEFIT-EXT Pharmacokinetic Analysis.

Alexandra Pyatt, Melissa McGowan, Ryota Tanaka

|Mar 25, 2024
Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians.

Alexander Wiseman, Tarek Alhamad, Rita R Alloway

|Jul 13, 2021
Plasma cell biology: Foundations for targeted therapeutic development in transplantation.

Amy P Rossi, Rita R Alloway, David Hildeman

|Jul 08, 2021
Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance: Two-Year Results of a Prospective, Randomized Multicenter Trial.

Dixon B Kaufman, E Steve Woodle, Adele Rike Shields

|Aug 27, 2020
Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection.

Meghan E Sise, David S Goldberg, Jens J Kort

|Nov 05, 2019
Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trial.

E Steve Woodle, Dixon B Kaufman, Adele R Shields

Pageof 3

Frequent Collaborators

10 joint publications

Ervin Steve Woodle

5 joint publications

Adele Rike-Shields

3 joint publications

David Hildeman

3 joint publications

Alexander Wiseman